SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-052999
Filing Date
2024-04-26
Accepted
2024-04-26 16:31:10
Documents
20
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242713-d7_def14a.htm   iXBRL DEF 14A 689893
6 GRAPHIC lg_protagonist-pn.jpg GRAPHIC 20224
7 GRAPHIC bc_companytsr-4c.jpg GRAPHIC 77397
8 GRAPHIC bc_netloss-4c.jpg GRAPHIC 71616
9 GRAPHIC px_24protagonistpage01-bw.jpg GRAPHIC 269122
10 GRAPHIC px_24protagonistpage02-bw.jpg GRAPHIC 239709
  Complete submission text file 0001104659-24-052999.txt   2945465

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20240331.xsd EX-101.SCH 7569
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptgx-20240331_def.xml EX-101.DEF 5592
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20240331_lab.xml EX-101.LAB 24524
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20240331_pre.xml EX-101.PRE 4755
23 EXTRACTED XBRL INSTANCE DOCUMENT tm242713-d7_def14a_htm.xml XML 98932
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37852 | Film No.: 24884392
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)